Intra-Cellular Therapies, a biopharmaceutical company, has appointed Michael Halstead as general counsel. In this role, Halstead will manage the company’s legal affairs, and will report directly to CEO Sharon Mates.
Intra-Cellular Therapies Names General Counsel
